U.S. to Back Covid-19 Vaccine Patent Waiver

The video discusses the stark contrast between the Trump and Biden administrations regarding IP waivers for COVID-19 vaccines. The Biden administration supports temporary waivers to aid developing countries, while the pharmaceutical industry expresses concerns about feasibility. The European Commission is open to discussions, highlighting the global debate on IP protection and public health.

In what ways does the discussion around patent waivers impact low and middle-income countries?

What are the potential political implications of granting waivers for IP patents in the U.S.?